VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 104 filers reported holding VERONA PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $895,327 | -32.6% | 54,928 | -12.6% | 0.00% | -50.0% |
| Q2 2023 | $1,328,120 | -5.4% | 62,825 | -10.1% | 0.00% | 0.0% |
| Q1 2023 | $1,403,612 | +8.0% | 69,901 | +40.5% | 0.00% | 0.0% |
| Q4 2022 | $1,300,020 | +176.0% | 49,752 | +7.9% | 0.00% | +100.0% |
| Q3 2022 | $471,000 | +2843.8% | 46,095 | +1100.4% | 0.00% | – |
| Q2 2022 | $16,000 | -15.8% | 3,840 | 0.0% | 0.00% | – |
| Q1 2022 | $19,000 | -26.9% | 3,840 | 0.0% | 0.00% | – |
| Q4 2021 | $26,000 | +23.8% | 3,840 | 0.0% | 0.00% | – |
| Q3 2021 | $21,000 | -16.0% | 3,840 | 0.0% | 0.00% | – |
| Q2 2021 | $25,000 | -21.9% | 3,840 | 0.0% | 0.00% | – |
| Q1 2021 | $32,000 | +18.5% | 3,840 | 0.0% | 0.00% | – |
| Q4 2020 | $27,000 | +12.5% | 3,840 | 0.0% | 0.00% | – |
| Q3 2020 | $24,000 | +33.3% | 3,840 | 0.0% | 0.00% | – |
| Q2 2020 | $18,000 | +12.5% | 3,840 | 0.0% | 0.00% | – |
| Q1 2020 | $16,000 | -27.3% | 3,840 | 0.0% | 0.00% | – |
| Q4 2019 | $22,000 | +22.2% | 3,840 | 0.0% | 0.00% | – |
| Q3 2019 | $18,000 | -10.0% | 3,840 | 0.0% | 0.00% | – |
| Q2 2019 | $20,000 | -20.0% | 3,840 | 0.0% | 0.00% | – |
| Q1 2019 | $25,000 | -28.6% | 3,840 | 0.0% | 0.00% | – |
| Q4 2018 | $35,000 | -27.1% | 3,840 | 0.0% | 0.00% | – |
| Q3 2018 | $48,000 | -7.7% | 3,840 | 0.0% | 0.00% | – |
| Q2 2018 | $52,000 | -32.5% | 3,840 | 0.0% | 0.00% | – |
| Q1 2018 | $77,000 | – | 3,840 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,111,112 | $11,356,000 | 29.98% |
| Aisling Capital Management LP | 1,332,485 | $13,618,000 | 9.04% |
| Abingworth LLP | 2,457,500 | $25,091,000 | 8.58% |
| Fairmount Funds Management LLC | 2,678,982 | $27,379,000 | 4.81% |
| Vivo Capital, LLC | 4,249,918 | $43,434,000 | 4.80% |
| NEA Management Company, LLC | 5,584,753 | $57,076,000 | 2.85% |
| Octagon Capital Advisors LP | 1,324,868 | $13,540,000 | 2.34% |
| Samsara BioCapital, LLC | 938,890 | $9,595,000 | 2.24% |
| ACT CAPITAL MANAGEMENT, LLC | 143,500 | $1,467,000 | 2.02% |
| Frazier Life Sciences Management, L.P. | 2,099,541 | $21,457,000 | 1.65% |